Connect with us


Novartis Sells Off Eye Health Drug

Eyevance bought the product.




FORT WORTH, TX — Eyevance Pharmaceuticals has acquired of Flarex 0.1% from Novartis AG.

Financial terms of the deal were not disclosed.

Flarex (fluorometholone acetate ophthalmic suspension), approved in the U.S., is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the eye, according to a press release.

“The acquisition of FLAREX escalates Eyevance’s mission to service important needs in the eye care market,” said Jerry St. Peter, CEO and director of Eyevance. “With over 9 million corticosteroids prescribed annually, at a compounded annual growth rate (CAGR) of 3.1% over the past five years, this large and invaluable therapeutic category provides Eyevance a tremendous opportunity with FLAREX. Corticosteroids are very important options for clinicians when treating ocular inflammation; FLAREX is a proven, well-accepted treatment for multiple ocular inflammatory conditions. Accordingly, it will become a valuable addition to our existing product portfolio, which includes several impactful products for conditions of the anterior segment.”

The purchase of Flarex “marks another important milestone for the Eyevance team,” according to the release. Eyevance’s portfolio consists of Zerviate cetirizine ophthalmic suspension 0.24% (licensed in September 2017 from Nicox Ophthalmics), FreshKote Preservative Free Tear Lubricant line (acquired in September 2018 from Focus Laboratories), and Nexagon (licensed in October 2018 from OcuNexus).


Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at [email protected].


Sponsored by Shamir

Customer Focused, Service Oriented, Forward Thinking

Shamir is the recognized world leader in custom-designed technology for life improvement, fashion, performance sports, occupational single vision, and progressive lenses. Our values, the driving force behind our ideas and actions, keep the ECP in the center. Every Shamir representative is personally committed to our customers’ vision, and to providing the best service and support to meet and exceed their expectations, all with a personal touch.

Click here for more information.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular